RETRACTED: Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin

Zhang, Shuhui; Zhou, Lin; Zhang, Mengdi; Wang, Yuehua; Wang, Mengqi; Du, Jincheng; Gu, Wenwen; Kui, Fuguang; Li, Jiahuan; Geng, Shengnan; Du, Gangjun

doi:10.3389/fphar.2019.01658

ORIGINAL RESEARCH article

Front. Pharmacol. , 29 January 2020

Sec. Pharmacology of Anti-Cancer Drugs

Volume 10 - 2019 | https://doi.org/10.3389/fphar.2019.01658

This article is part of the Research Topic Multi-targeted Natural Products as Cancer Therapeutics: Challenges and Opportunities, Volume I View all 54 articles

RETRACTED: Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin

Retracted

A retraction of this article was approved in:

Retraction: Berberine maintains the neutrophil N1 phenotype to reverse cancer cell resistance to doxorubicin
1. Read retraction

Shuhui Zhang^1†

Lin Zhou^1†

Mengdi Zhang¹

Yuehua Wang¹

Mengqi Wang¹

Jincheng Du^1,3

Wenwen Gu¹

Fuguang Kui¹

Jiahuan Li^1*

Shengnan Geng^2*

Gangjun Du^1,2*

¹Institute of Pharmacy, Pharmaceutical College of Henan University, Kaifeng, China
²School of Pharmacy and Chemical Engineering, Zhengzhou University of Industry Technology, Xinzheng, China
³Chinese Medical School, Hunan University of Chinese Medicine, Changsha, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Keywords: berberine, doxorubicin, neutrophil phenotype, carcinogenesis, chemotherapeutic resistance

Citation: Zhang S, Zhou L, Zhang M, Wang Y, Wang M, Du J, Gu W, Kui F, Li J, Geng S and Du G (2020) Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin. Front. Pharmacol. 10:1658. doi: 10.3389/fphar.2019.01658

Received: 06 November 2019; Accepted: 17 December 2019;
Published: 29 January 2020; Retracted: 07 December 2023.

Edited by:

Jiangjiang Qin, Zhejiang Chinese Medical University, China

Reviewed by:

Dan Shao, South China University of Technology, China
Qiao Liu, Shandong University, China

^†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

RETRACTED: Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good